{"id":"NCT00990184","sponsor":"Seattle Institute for Biomedical and Clinical Research","briefTitle":"Study to Evaluate the Effects of Colesevelam on Insulin Sensitivity and ß-Cell Function in Subjects With Impaired Fasting Glucose (Prediabetes)","officialTitle":"A Single-Blind Study to Evaluate the Effects of Colesevelam on Insulin Sensitivity and ß-Cell Function in Subjects With Impaired Fasting Glucose (Prediabetes)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-09","primaryCompletion":"2010-10","completion":"2010-10","firstPosted":"2009-10-06","resultsPosted":"2012-11-21","lastUpdate":"2012-11-21"},"enrollment":21,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Impaired Fasting Glucose","Prediabetes"],"interventions":[{"type":"DRUG","name":"Colesevelam","otherNames":["colesevelam HCl"]},{"type":"OTHER","name":"placebo","otherNames":[]}],"arms":[{"label":"Colesevelam Hydrochloride","type":"EXPERIMENTAL"}],"summary":"The objective of this study is to determine the effect of 8 weeks of treatment with colesevelam HCl 3.75 g once daily with the evening meal on ß-cell function by evaluating the acute insulin response (AIRg) to an intravenous glucose load in subjects with prediabetes (impaired fasting glucose).","primaryOutcome":{"measure":"Acute Insulin Response (AIRg) to Intravenous Glucose","timeFrame":"Baseline and 8 weeks","effectByArm":[{"arm":"Colesevelam","deltaMin":1866,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":16},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["22446171"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":21},"commonTop":["Constipation","Cholelithiasis"]}}